Log in to search using one of your social media accounts:

 

duloxetine, Cymbalta
Title: duloxetine, CymbaltaCategory: MedicationsCreated: 7/11/2007 12:00:00 AMLast Editorial Review: 8/29/2017 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - August 29, 2017 Category: Psychiatry Source Type: news

Class 3 Medicines Recall: Specific batches of Torrent Dutor (Duloxetine) Gastro-resistant Capsules
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for specified batches of Torrent Dutor (Duloxetine) Gastro-resistant Capsules. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 31, 2017 Category: Drugs & Pharmacology Source Type: news

Can Cymbalta Help Nerve Damage in the Spine?
Title: Can Cymbalta Help Nerve Damage in the Spine?Category: Doctor's& Expert's views on SymptomsCreated: 7/25/2017 12:00:00 AMLast Editorial Review: 7/25/2017 12:00:00 AM (Source: MedicineNet Chronic Pain General)
Source: MedicineNet Chronic Pain General - July 25, 2017 Category: Anesthesiology Source Type: news

Not Just for Attention: Stop Teen Suicide
The subject of depression and suicide, especially in the case of children and teens, is a tremendous concern. Unfortunately, many cases go missed not necessarily because those surrounding these young people don’t care or pay enough attention to them, but more because they aren’t aware of what to look out for. I am a suicide survivor. I also grew up with a suicidal mother and witnessed a peer successfully commit suicide, ironically, when I was in the emergency room beside her being treated for the same thing. I was saved, while her family still mourns for her. These experiences, including the fact that my twelve...
Source: Psych Central - March 29, 2017 Category: Psychiatry Authors: Chynna Laird Tags: Antidepressants Children and Teens Depression Medications Personal Stories Self-Esteem Stress Suicide Therapists Spill Treatment Anxiety Coping Skills Depression Mood Depressive Episode Major Depressive Disorder Monoamine Oxi Source Type: news

Which Drugs Work for Diabetic Peripheral Neuropathy Pain? (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH Duloxetine, venlafaxine, pregabalin, oxcarbazepine, tricyclic antidepressants, atypical opioids (e.g., tapentadol), and botulinum toxin are all more effective than placebo in reducing … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 27, 2017 Category: Primary Care Source Type: news

Duloxetine Monotherapy in Chronic Low Back Pain Duloxetine Monotherapy in Chronic Low Back Pain
Duloxetine monotherapy may be a safe and effective treatment option for chronic low back pain.Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2016 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Patient with 108-Degree Fever Shows Seriousness of Early Recognition & Treatment of Hyperthermia
Medic 35 is dispatched to a local subdivision for an obese 62-year-old woman with syncope. The responding unit is a fire-based ALS unit staffed by two paramedics. Patient Assessment It's approximately 2:30 p.m., with outside temperatures reaching 95 degrees F and the humidity is at 65%.The patient is lying in the grass next to a picnic blanket and paper plates with half eaten sandwiches. Her husband crouches over her. He says his wife started to complain she felt unwell, and then passed out. Upon evaluation, she's unresponsive to sternal rub. Her airway is patent. Her breaths are rapid and shallow with rales bilaterally. H...
Source: JEMS Patient Care - November 1, 2016 Category: Emergency Medicine Authors: Christine M. Brent, MD Tags: Patient Care Source Type: news

Cymbalta (Duloxetine Hcl) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 22, 2016 Category: Drugs & Pharmacology Source Type: news

Accused murderer Richard Bain says he has no memory of election-night shooting
Richard Bain, dressed in a suit and tie, told the jury on Monday that he had no memory of the shooting at the Metropolis and that an anti-depressant called Cymbalta was making it difficult for him to tell the difference between right and wrong. (Source: CBC | Health)
Source: CBC | Health - July 18, 2016 Category: Consumer Health News Tags: News/Canada/Montreal Source Type: news

Fentanyl can cause serotonin syndrome
3.5 out of 5 stars Serotonin Syndrome Induced by Fentanyl in a Child: Case Report. Robles LA. Clin Neuropharmacol 2015 Sept-Oct;38:206-8. Abstract When many clinicians think of serotonin syndrome (SS), they consider the usual suspects: Selective Serotonin Uptake Inhibitors (SSRIs) Citalopram Fluoxetine Sertraline Escitalopram Paroxetine Serotonin-Norepinephrine Reuptake Inhibitors Venlafaxine Duloxetine Antidepressants Trazodone Buspirone Clomipramine Aside from these common culprits, there are other commonly used drugs whose clear association with serotonin syndrome is less-often realized: Fentanyl ...
Source: The Poison Review - July 8, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical fentanyl opioid serotonin syndrome Source Type: news

Depression blood test could lead to personalised treatments
Conclusion This study shows how a new blood test in development can help identify people with depression who are most and least likely to benefit from antidepressants. While promising, the test is far from perfect. For example, it missed 39-43% of non-responders, meaning these people would continue to receive standard antidepressant treatment that is unlikely to work for them. A large proportion of patients (22-38%) also fell into the "intermediate" group who were neither responders nor non-responders, so the test wasn't too useful here. This means there is a significant proportion of people with...
Source: NHS News Feed - June 7, 2016 Category: Consumer Health News Tags: Mental health Medication Source Type: news

Antidepressants linked to suicide and aggression in teens
ConclusionPerhaps the most troubling aspect of this paper is not the increased risk of suicidal thoughts in young people, as that has been known for many years. What is worrying is the researchers’ conclusion that they are unable to tell the true extent of harms from antidepressants, because of poor data collection and availability.RCTs are designed to test the effects of treatments with as little bias as possible. However, if the right data on adverse effects is not collected in the trials, or is not made public, we cannot balance the benefits and risks of treatment in a fair and transparent way. According to the da...
Source: NHS News Feed - January 28, 2016 Category: Consumer Health News Tags: Mental health Medication Source Type: news

Depression medication could help knee osteoarthritis
Researchers at our pain centre are recruiting people to take part in a clinical trial to determine whether duloxetine, a drug normally used to help people with anxiety or depression, can also be effective against the pain of knee osteoarthritis. Current treatments for tackling osteoarthritis are limited. If results from the trial are positive, it could provide a new treatment option for millions of people living with chronic knee pain. Diane Reckziegel, from The University of Nottingham and chief investigator for the study, said: “Duloxetine has already been shown to be effective in relieving different types of chron...
Source: Arthritis Research UK - December 23, 2015 Category: Rheumatology Source Type: news

Make the Diagnosis: Senior's Skin Affliction
(MedPage Today) -- Case Findings: A 60-year-old woman presents and describes a history of intermittent episodes of fluid-filled blisters on her abdomen, back, and arms. When the blisters ruptured, they caused moist erosions that led to post-inflammatory hyperpigmentation in the form of pink lesions. She had been taking Cymbalta, and the condition persisted when she discontinued the medication. What is your diagnosis? (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 24, 2015 Category: Dermatology Source Type: news

Living with Panic Attacks
You’re sitting in your car trying to will yourself to walk into the grocery store. Anxiety washes over you. You’re cold and hot at the same time with sweat trickling down your back, hair standing on your arms. You finally get out of your car. But as you enter the store, you feel wobbly and like you’re going to pass out. The fluorescent lighting seems especially stifling. The wide aisles, oddly enough, feel claustrophobic. Your breath feels finite, like a balloon floating up to the sky, which you can’t catch. In fact, at times you feel like you’re floating along with the balloon. At times you f...
Source: Psych Central - September 3, 2015 Category: Psychiatry Authors: Margarita Tartakovsky, M.S. Tags: Anxiety Cognitive-Behavioral Disorders General Psychotherapy Relaxation and Meditation Self-Esteem Self-Help Stress Academy of Cognitive Therapy Agoraphobia Antidepressant Anxiety Disorder Association for Behavioral and Cognitive Source Type: news

Lupin launches 40 mg Duloxetine DR capsules in the US
Lupin is now the only generic manufacturer to offer all Duloxetine dosage strengths - the 20 mg, 30 mg, 60 mg, and now the newest 40 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 3, 2015 Category: Pharmaceuticals Source Type: news

U.S. jury clears Eli Lilly in first Cymbalta withdrawal trial
(Reuters) - Eli Lilly on Friday was cleared of liability in the first trial involving claims that its antidepressant Cymbalta caused severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations, the company said. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Eli Lilly faces first U.S. trials over Cymbalta withdrawal
NEW YORK (Reuters) - Eli Lilly & Co on Tuesday will confront the first U.S. trial over allegations it failed to warn users of its popular antidepressant Cymbalta that they could suffer severe withdrawal symptoms, including suicidal thoughts and electric shock-like sensations. (Source: Reuters: Health)
Source: Reuters: Health - August 3, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

CHMP Backs Three Generics for Major Mental IllnessesCHMP Backs Three Generics for Major Mental Illnesses
The EMA committee gives green light to Duloxetine Zentiva, Aripiprazole Sandoz, and Pregabalin Accord. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - June 26, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news

Lilly Heads to Court Over Cymbalta "Brain Zap" Withdrawal Issues
Eli Lilly will face jury trials in August for claims it misled consumers about withdrawal side effects tied to its antidepressant Cymbalta. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 25, 2015 Category: Pharmaceuticals Source Type: news

Medication and Anxiety
Medication can be an effective approach for managing various types of anxiety such as panic, hyperarousal, and constant worry. However, contrary to popular belief and subtle messages from pharmaceutical companies, medication is far from a cure. In fact, when it comes to “cures” for most psychiatric conditions, the data tends to support psychotherapy. For example, post-traumatic stress disorder (PTSD) responds very well to psychotherapy, whereas the positive effects of medication are somewhat limited. The same is true for panic disorder. Although certain types of medication are very good at relieving panic sympt...
Source: Psych Central - March 11, 2015 Category: Psychiatry Authors: Bret Moore, PsyD Tags: Anti-anxiety Antidepressants Benzodiazepines Disorders General Medications Panic Disorder anti-anxiety medications Drug Dependency Fear Hyperarousal Sedatives Selective Serotonin Reuptake Inhibitor snri Ssri Substance Abuse Source Type: news

Drug interactions more common and costly for duloxetine
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 27, 2014 Category: Drugs & Pharmacology Source Type: news

Retrospective review of nutmeg toxicity
2.5 out of 5 stars Nutmeg Poisonings: A Retrospective Review of 10 Years Experience from the Illinois Poison Center: 2001-2011. Ehrenpreis JE et al. J Med Toxicol 2014;10:148-151. Abstract Just when you thought it was safe to go back to the eggnog bowl . . . Nutmeg is the seed of the aromatic evergreen Myristica fragrans. It contains a number of volatile oils, some of which may be metabolized to monoamine oxidase inhibitors or amphetamine-like substances. Manifestations of nutmeg toxicity are quite similar to those of the anticholinergic syndrome, including dry mouth, flushing, tachycardia, tremor, urinary r...
Source: The Poison Review - July 10, 2014 Category: Toxicology Authors: Leon Tags: Medical anticholinergic syndrome myristica fragrans nutmeg Source Type: news

A Cold Splash - Hydrotherapy for Depression and Anxiety
Can hot and cold water help mood? Ancient wisdom and some modern research suggest it may. read more (Source: Psychology Today Anxiety Center)
Source: Psychology Today Anxiety Center - July 6, 2014 Category: Psychiatry & Psychology Authors: Peter Bongiorno, ND, LAc Tags: Anxiety Depression Integrative Medicine Psychiatry alternative medicine cold shower Cymbalta duloxetine electroconvulsive Therapy hippocrates hydrotherapy mood naturopathic medicine naturopathy polar bear club SNRI ssri ant Source Type: news

A Cold Splash–Hydrotherapy for Depression and Anxiety
Can hot and cold water help mood? Ancient wisdom and some modern research suggest it may. read more (Source: Psychology Today Anxiety Center)
Source: Psychology Today Anxiety Center - July 6, 2014 Category: Psychiatry & Psychology Authors: Peter Bongiorno, ND, LAc Tags: Anxiety Depression Integrative Medicine Psychiatry alternative medicine cold shower Cymbalta duloxetine electroconvulsive Therapy hippocrates hydrotherapy mood naturopathic medicine naturopathy polar bear club SNRI ssri ant Source Type: news

Dr Reddy's Lab launches duloxetine delayed-release capsules
Cymbalata (duloxetine delayed- release capsules) brand and generic had US sales of $5.04 billion for the most recent 12 months ending April 2014. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 27, 2014 Category: Pharmaceuticals Source Type: news

Coding of adverse events of suicidality in clinical study reports of duloxetine for the treatment of major depressive disorder: descriptive study - Maund E, Tendal B, Hróbjartsson A, Lundh A, Gøtzsche PC.
OBJECTIVE: To assess the effects of coding and coding conventions on summaries and tabulations of adverse events data on suicidality within clinical study reports. DESIGN: Systematic electronic search for adverse events of suicidality in tables, na... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - June 16, 2014 Category: Global & Universal Tags: Research Methods, Surveillance and Codes, Models Source Type: news

Is Duloxetine more or less effective than Fluoxetine in children and teens with MDD?
(Mary Ann Liebert, Inc./Genetic Engineering News) Two studies of the anti-depressive drug duloxetine, a serotonin-norepinephrine reuptake inhibitor, compared its effectiveness and safety to either fluoxetine or placebo in children and adolescents with major depressive disorder. The results of these first controlled trials of duloxetine in pediatric patients with MDD are published in Journal of Child and Adolescent Psychopharmacology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 19, 2014 Category: Global & Universal Source Type: news

Medical Marijuana Rated Much More Effective in Treating Fibromyalgia Symptoms Than Drugs
The three drugs approved for the treatment of fibromyalgia are Cymbalta (Duloxetine); Lyrica (Pregabalin); and Savella (Milnacipran). (Source: Disabled World)
Source: Disabled World - April 21, 2014 Category: Disability Tags: Fibromyalgia Source Type: news

Generic Cymbalta - Is Duloxetine Safe?
In December of 2013 the US Food and Drug Administration approved a generic version of the antidepressant Cymbalta. As the manufacturer's patent expires and the cheaper generic becomes available, it's good news for many. Cymbalta is expensive! (I know, because I take it, and it's the costliest drug in my medication arsenal.) But close on the heels of this approval comes word from Australia that there have been 21 confirmed cases where patients taking duloxetine - already in use there - in doses from 30 to 120mg/day developed the dangerous condition called serotonin syndrome. In ten additional cases Read Full PostGeneric Cy...
Source: About.com Bipolar Disorder - February 28, 2014 Category: Psychiatry Source Type: news

Adherence to Duloxetine Treatment Published by Dove Medical Press
Adherence among newly initiated duloxetine patients varied modestly across the medical conditions for which it was used.(PRWeb February 12, 2014)Read the full story at http://www.prweb.com/releases/2014/02/prweb11577512.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 12, 2014 Category: Pharmaceuticals Source Type: news

FDA approves first generic versions of antidepressant drug Cymbalta
The U.S. Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharma Global FZE, Teva Pharmaceuticals USA, and Torrent Pharmaceuticals Ltd. have received FDA approval to market duloxetine in various strengths. "Health care professionals and consumers can be assured that these FDA-approved generic drugs have met our rigorous standards," said Kathleen Uhl, M.D. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 16, 2013 Category: Consumer Health News Tags: Depression Source Type: news

FDA approves generic versions of antidepressant Cymbalta
WASHINGTON, Dec. 14 (UPI) -- The U.S. Food and Drug Administration approved the first generic versions of Cymbalta, a drug used to treat depression and other conditions, officials say. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 15, 2013 Category: Consumer Health News Source Type: news

FDA Approves Generic Versions of Lilly's Antidepressant Cymbalta
The FDA has granted approval for the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription antidepressant that is currently Eli Lilly's top-selling drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - December 12, 2013 Category: Pharmaceuticals Source Type: news

FDA OK's Generic Versions of Antidepressant Cymbalta
FDA Approves Generic Versions of Antidepressant Cymbalta (Source: WebMD Health)
Source: WebMD Health - December 12, 2013 Category: Consumer Health News Source Type: news

Sun Pharma gets USFDA nod for anti-depressant drug
The company said its subsidiary has received nod from the US Food and Drug Administration to market Duloxetine Delayed-Release Capsules. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2013 Category: Pharmaceuticals Source Type: news

Generic Cymbalta Approved
Title: Generic Cymbalta ApprovedCategory: Health NewsCreated: 12/11/2013 7:36:00 PMLast Editorial Review: 12/12/2013 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - December 12, 2013 Category: Psychiatry Source Type: news

Several Indian companies get FDA nod for anti-depressant drug
The US Food and Drug Administration has approved the first generic versions of Cymbalta, a prescription medicine used in treatment of depression. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 12, 2013 Category: Pharmaceuticals Source Type: news

Generic Cymbalta Approved (FREE)
By the Editors The FDA has approved generic versions of the … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 12, 2013 Category: Primary Care Source Type: news

FDA Okays First Cymbalta GenericsFDA Okays First Cymbalta Generics
The FDA has approved the first generic versions of the antidepressant Cymbalta. FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2013 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

FDA approves generics of Lilly antidepressant Cymbalta
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved generic versions of Eli Lilly and Co's antidepressant Cymbalta, the U.S. drugmaker's biggest-selling product. (Source: Reuters: Health)
Source: Reuters: Health - December 11, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves first generic versions of antidepressant drug Cymbalta
The U.S. Food and Drug Administration today approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and other conditions. (Source: Food and Drug Administration)
Source: Food and Drug Administration - December 11, 2013 Category: American Health Source Type: news

A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose - Taylor D, Lenox-Smith A, Bradley A.
Depression and anxiety disorders are among the most common disorders treated by general practitioners (GPs) in the UK. Since both disorders are associated with a significantly increased risk of suicide, including with antidepressant overdose, the safety of... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - November 15, 2013 Category: Global & Universal Tags: Poisoning Source Type: news

Duloxetine Prophylaxis for Episodic MigraineDuloxetine Prophylaxis for Episodic Migraine
Could the SNRI duloxetine be effective for the prevention of migraine? Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Dr. Timothy J. Garnett, FRCOG, MFFP, FFPM
Chief Medical Officer & SVP, Development Center of Excellence, Eli Lilly & CompanyDr. Timothy Garnett, FRCOG, MFFP, FFPM, is Chief Medical Officer, Senior Vice-President and Co-Leader of the Development Center of Excellence managing Medical Affairs, Global Health Outcomes, Regulatory, Safety and Translational Medicine/Pharmacogenomics for Eli Lilly and Company. During his 14 years at Lilly, Dr. Garnett has served as Vice President for Global Patient Safety; Global Brand Development Leader and Group Medical Director responsible for the development of Duloxetine for incontinence, pain and depression; Medical Director...
Source: PHRMA - November 5, 2013 Category: Pharmaceuticals Authors: Leah Source Type: news

Dr. Timothy J. Garnett
Chief Medical Officer & SVP, Eli Lilly & CompanyDr. Timothy Garnett, FRCOG, MFFP, FFPM, is Chief Medical Officer, Senior Vice-President and Co-Leader of the Development Center of Excellence managing Medical Affairs, Global Health Outcomes, Regulatory, Safety and Translational Medicine/Pharmacogenomics for Eli Lilly and Company. During his 14 years at Lilly, Dr. Garnett has served as Vice President for Global Patient Safety; Global Brand Development Leader and Group Medical Director responsible for the development of Duloxetine for incontinence, pain and depression; Medical Director Duloxetine SUI Team; and European...
Source: PHRMA - November 5, 2013 Category: Pharmaceuticals Authors: Leah Source Type: news

Lilly beats forecast, cuts costs before Cymbalta fades
(Reuters) - Eli Lilly and Co reported higher-than-expected quarterly earnings on Wednesday as it slashed costs ahead of generic competition later this year for its biggest product, antidepressant Cymbalta, and raised its 2013 profit view on plans for more streamlining. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Lilly beats forecast, helped by soon-fading Cymbalta
(Reuters) - Eli Lilly and Co reported higher-than-expected quarterly earnings, helped by cost cuts and strong sales of Cymbalta, a depression treatment that will lose patent protection by year end, and the drugmaker raised its full-year profit forecast. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

Eli Lilly Freezes Salaries as Patents Expire
Eli Lilly and Company is freezing salaries for most employees in 2014 to reduce costs. Officials said the company would also reduce bonuses paid out in 2015 for 2014 employee performances. "This is a difficult, but necessary decision. While we remain confident in our future, we continue to face the most significant challenges in our history. We expect to lose about 20 percent of our global revenue in 2014 because of the expiration of the Cymbalta and Evista patents in the U.S. While we've taken many actions to reduce costs and become a leaner organization, we must do more. We estimate these actions will enable us to ...
Source: PharmaManufacturing.com - July 18, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Cymbalta Side Effects (Duloxetine)
Cymbalta (duloxetine) is an antidepressant medication that is also used to treat diabetic neuropathy. It is classed as an SNRI - Serotonin-Norepinephrine Reuptake Inhibitor. It is used to treat depressive symptoms including the aches and pains that can be caused by depression. This page lists the best-known Cymbalta side effects. (Source: About.com Bipolar Disorder)
Source: About.com Bipolar Disorder - July 4, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news